Celexa and Oxaliplatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Celexa (citalopram hydrobromide) and Oxaliplatin (oxaliplatin). Common drug interactions include haemoglobin decreased among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Celexa and Oxaliplatin. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Celexa?

Celexa has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 56,390 Celexa users. Check the latest studies of Celexa.

What is Oxaliplatin?

Oxaliplatin has active ingredients of oxaliplatin. It is often used in colon cancer. eHealthMe is studying from 72,058 Oxaliplatin users. Check the latest studies of Oxaliplatin.



On Jul, 18, 2026

48 people who take Celexa and Oxaliplatin together, and have interactions are studied.

Celexa and Oxaliplatin drug interactions.

What are the common drug interactions of Celexa and Oxaliplatin, by gender? *:

female:

  1. Haemoglobin decreased
  2. Hepatic steatosis (fatty liver disease)
  3. Hyperhidrosis (abnormally increased sweating)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Hypokalaemia (low potassium)
  6. Infection
  7. Loss of consciousness
  8. Malignant neoplasm progression (cancer tumour came back)
  9. Metastases to lung (cancer spreads to lung)
  10. Metastases to ovary (cancer spreads to ovary)

male:

  1. Headache (pain in head)
  2. Pyrexia (fever)
  3. Visual impairment
  4. Angina pectoris (chest pain due to ischemia of the heart muscle)
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  6. Blindness
  7. Chest pain
  8. Confusional state
  9. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  10. Cough

What are the common drug interactions of Celexa and Oxaliplatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Asthenia (weakness)
  2. Back pain
  3. Bone pain
  4. Chest pain
  5. Diarrhoea
  6. Functional gastrointestinal disorder (functional problem in separate organs of gastrointestinal system)
  7. General physical health deterioration (weak health status)
  8. Haemoglobin decreased
  9. Hypokalaemia (low potassium)
  10. Intestinal obstruction

50-59:

  1. Syncope (loss of consciousness with an inability to maintain postural tone)
  2. Vomiting
  3. Diarrhoea
  4. Cholangitis (infection of the bile duct)
  5. Nausea (feeling of having an urge to vomit)
  6. Cholecystitis acute (rapid infection of gallbladder)
  7. Dehydration (dryness resulting from the removal of water)
  8. Hypotension (abnormally low blood pressure)
  9. Pancreatitis (inflammation of pancreas)
  10. Catheter related infection

60+:

  1. Pyrexia (fever)
  2. Decreased appetite
  3. Visual impairment
  4. Angina pectoris (chest pain due to ischemia of the heart muscle)
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  6. Blindness
  7. Chest pain
  8. Confusional state
  9. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  10. Disorientation (disability in which the senses of time, direction, and recognition of people and places)

What are the existing conditions these people have? *

  1. Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 6 people, 12.50%
  2. Neuroendocrine Carcinoma (cancer tumour that arise from cells of the endocrine (hormonal) and nervous systems): 5 people, 10.42%
  3. Adenocarcinoma Pancreas (cancer of pancreas): 5 people, 10.42%
  4. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 4 people, 8.33%
  5. Stress And Anxiety: 3 people, 6.25%
  6. Nausea (feeling of having an urge to vomit): 3 people, 6.25%
  7. Insomnia (sleeplessness): 3 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Celexa and Oxaliplatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Celexa and Oxaliplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Celexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxaliplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Celexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxaliplatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide and oxaliplatin (the active ingredients of Celexa and Oxaliplatin, respectively), and Celexa and Oxaliplatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: